Digital Health Startups
6,443 companies tagged Digital Health, with their investors and founders.
Hims offers personalised healthcare through online consultations with licensed medical providers, creating individual treatment plans and delivering prescription and generic treatments direct to customers. It provides ongoing access to a care team and health content, serving consumers in the UK.
2 investors
Honeybee Health is a mail-order pharmacy based in California that fills prescription and over-the-counter medications, selling generic drugs at transparent, low prices without insurance. It serves patients directly as well as telehealth platforms and practitioners through a prescription fulfillment partnership program, and can also fill prescriptions for pets.
2 investors
Hoopcare provides HIPAA-compliant AI-powered clinical tools for healthcare professionals to extract patient data from EHRs, generate preoperative notes, and identify clinical insights. The platform is designed for U.S. healthcare professionals and aims to reduce administrative burden.
2 investors
Hopia is an AI platform that automates staff scheduling for doctors and caregivers across all hospital departments, using a proprietary symbolic AI to model legal, collective, and individual rules. It serves public hospitals, private clinics, ESPIC, GHT, and EHPAD facilities in France, and connects to hospital IT and HR systems (SIH/SIRH).
2 investors
HILO is a Hokkaido University spin-out commercializing a drug-efficacy evaluation method based on fluorescence bioimaging technology developed by Professor Yusuke Ohba. The company operates a registered clinical testing laboratory and serves pharmaceutical research and development applications.
2 investors
Hormona provides digital health resources and education for women's hormonal health management across all life stages. The platform addresses knowledge gaps and helps women understand and manage hormonal well-being.
2 investors
Hoth builds augmented reality software for healthcare providers to assist with viewing and performing medical procedures. Its system is designed to be lightweight and to expand capabilities across multiple medical specialties.
2 investors
Human First developed Atlas, a platform providing evidence and insights related to digital health measurement; the company and its Atlas product have been acquired by ICON. Atlas continues to serve existing customers with digital health data and insights, now with capabilities developed alongside ICON's Mapi Research Trust.
2 investors
TELUS Health Engage (Humanoo) is a corporate wellbeing platform that offers employees guided programs in fitness, mindfulness, and nutrition alongside coaching, challenges, and community features. It provides HR teams with engagement, survey, and program insights through dashboards and quarterly reports to track workforce wellbeing, detect stress signals, and measure ROI.
2 investors
Huna provides an AI-powered platform to healthcare institutions for early cancer detection and patient management. The software uses institutional data and machine learning algorithms to identify high-risk patients, optimize screening workflows, and reduce diagnosis time for breast, colorectal, prostate, lung, and cervical cancers.
2 investors
Hurdle provides a modular diagnostic infrastructure platform with APIs and low/no-code tools for ordering diagnostics, integrating results with EHRs, and coordinating sample collection. It serves clinics, digital health providers, diagnostics companies, and research institutions, and offers an AI-driven multi-omics platform for biomarker discovery and precision medicine.
2 investors
Develops an at-home device that measures bladder and urinary symptoms in men and generates a report for healthcare providers to support clinical decisions. Serves patients experiencing urinary symptoms and their clinicians in the urology care space.
2 investors
iCorNet develops a tailored cardiac remodeling prevention net using 3D cardiac imaging and computer-controlled knitting technology to treat dilated cardiomyopathy. The device is designed for heart failure patients who do not respond adequately to drug therapy and cannot access cardiac transplantation.
2 investors
Igentify provides clinical patient communication software that guides patients through education, consent, and results in their own language, reducing provider workload for diagnostics and genetics labs. It also offers data validation tooling that reads, validates, and routes incoming lab records to cut manual re-entry and errors.
2 investors
Ikerian applies data and AI to identify biomarkers linked to chronic and systemic disorders, aggregate clinical insights, and support treatment decisions. The company serves healthcare stakeholders and drug developers by curating information and optimizing clinical workflows and operations.
2 investors
Illimis Therapeutics is a biotech company developing therapeutics for intractable diseases, including GAIA-AΞ², a treatment aimed at improving Alzheimer's disease by clearing beta-amyloid via an efferocytosis-based mechanism that avoids the ARIA side effects of existing treatments. The company focuses on translating life science research into medicines for patients.
2 investors
Illumicell develops AI-driven tools for early diagnosis and clinical decision support in healthcare, with a focus on deploying solutions in hospital settings. The company combines advanced artificial intelligence with cloud infrastructure and high-performance computing to deliver clinically meaningful solutions for medical specialties.
2 investors
Illumina Ventures is a venture capital firm focused on genomics and precision health investing. It backs companies working to advance innovation and impact in human health.
2 investors
ImageMover offers software that captures photos of COVID-19 test kit results and links them to the test subject along with demographic data, then stores the images in health system archives, EHRs, or regional and work-related databases. The tool is aimed at health systems needing documented records of rapid test results.
2 investors
Imagenomix develops AI recognition software that infers cancer genetics from pathology slide images, providing molecular diagnostic information in minutes rather than weeks. It targets oncologists and hospitals to expand access to affordable genomic testing and targeted therapy for cancer patients.
2 investors
Imagine Pediatrics provides virtual pediatric care for children, offering 24/7 access to a care team of pediatric nurses and doctors through an app and phone line. Families check eligibility, download the app, and connect with clinicians for both immediate and acute care needs.
2 investors
Imprivata is a digital identity company that supports community outreach and corporate social responsibility initiatives through its employee-founded Imprivata Cares organization. The company organizes donation drives, hands-on volunteer projects, and mentoring partnerships focused on local communities.
2 investors
ImYoo is a Public Benefit Corporation that provides at-home immune sample collection kits and molecular profiling to map patients' experiences to their underlying biology. It works directly with participants ("patient scientists") on immune-focused research studies, delivering research reports as part of a precision medicine approach.
2 investors
Inbiomotion develops the MAF Test, a biomarker diagnostic based on MAF gene expression that helps doctors select early breast cancer patients for adjuvant bisphosphonate treatment. The test aims to identify MAF-negative patients who benefit from therapy while excluding MAF-positive patients who may not benefit or could be harmed.
2 investors